Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
89 hedge funds and large institutions have $364M invested in Aratana Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
50% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 24
10% more funds holding
Funds holding: 81 → 89 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $396M → $364M (-$31.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $48K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$14.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.1M |
| 3 |
Jennison Associates
New York
|
+$7.5M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.34M |
| 5 |
AP
Alydar Partners
Boston,
Massachusetts
|
+$2.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$9.84M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.26M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
-$4.41M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$4.25M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.85M |
PETX Hedge Fund Activity: Q2 2014 in Review
89 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q2 2014, worth a combined $364M — down 8% from $396M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PETX positions and 9 closed out — a net gain of 8 holders — while 36 added to existing stakes and 24 trimmed.
The largest buyer was Franklin Resources, adding an estimated $14.9M. The largest seller was MPM Asset Management, cutting an estimated $9.84M.
- 89 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q2 2014, up from 81 in Q1 2014.
- Funds reported $364M of Aratana Therapeutics, Inc. stock for Q2 2014, down 8% quarter-over-quarter.
- 17 funds opened new Aratana Therapeutics, Inc. positions in Q2 2014 and 9 closed out, a net change of +8 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q2 2014 was Franklin Resources, an estimated $14.9M added.
- The largest Aratana Therapeutics, Inc. seller in Q2 2014 was MPM Asset Management, an estimated $9.84M sold.
Based on aggregated 13F filings for Q2 2014.